GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Regenerative Medicine International Ltd (HKSE:08158) » Definitions » Shiller PE Ratio

China Regenerative Medicine International (HKSE:08158) Shiller PE Ratio : (As of May. 10, 2025)


View and export this data going back to 2001. Start your Free Trial

What is China Regenerative Medicine International Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


China Regenerative Medicine International Shiller PE Ratio Historical Data

The historical data trend for China Regenerative Medicine International's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Regenerative Medicine International Shiller PE Ratio Chart

China Regenerative Medicine International Annual Data
Trend Apr15 Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

China Regenerative Medicine International Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of China Regenerative Medicine International's Shiller PE Ratio

For the Biotechnology subindustry, China Regenerative Medicine International's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Regenerative Medicine International's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, China Regenerative Medicine International's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where China Regenerative Medicine International's Shiller PE Ratio falls into.


;
;

China Regenerative Medicine International Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

China Regenerative Medicine International's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, China Regenerative Medicine International's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0/117.2957*117.2957
=0.000

Current CPI (Jun. 2024) = 117.2957.

China Regenerative Medicine International Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201404 -3.582 96.409 -4.358
201407 -0.614 97.288 -0.740
201410 -0.662 99.267 -0.782
201501 -0.702 99.377 -0.829
201504 -2.058 99.157 -2.434
201507 -0.542 99.817 -0.637
201510 -0.264 101.466 -0.305
201601 -0.770 101.906 -0.886
201604 -0.630 101.796 -0.726
201607 -0.868 102.125 -0.997
201610 -0.704 102.675 -0.804
201701 0.130 103.225 0.148
201704 -0.657 103.884 -0.742
201707 -0.696 104.104 -0.784
201710 -0.720 104.324 -0.810
201803 -0.608 105.973 -0.673
201806 -1.534 106.193 -1.694
201809 -0.640 106.852 -0.703
201812 -10.792 107.622 -11.762
201903 -0.417 108.172 -0.452
201906 -0.274 109.601 -0.293
201909 -0.252 110.260 -0.268
201912 -4.157 110.700 -4.405
202003 -0.171 110.920 -0.181
202006 -1.213 110.590 -1.287
202009 -0.097 107.512 -0.106
202012 -0.778 109.711 -0.832
202103 -0.027 111.579 -0.028
202106 0.083 111.360 0.087
202109 0.012 109.051 0.013
202112 -0.022 112.349 -0.023
202203 0.004 113.558 0.004
202206 0.004 113.448 0.004
202209 0.029 113.778 0.030
202212 -0.021 114.548 -0.022
202303 0.000 115.427 0.000
202306 0.039 115.647 0.040
202309 0.029 116.087 0.029
202312 -0.399 117.296 -0.399
202406 0.000 117.296 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China Regenerative Medicine International  (HKSE:08158) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


China Regenerative Medicine International Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of China Regenerative Medicine International's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Regenerative Medicine International Business Description

Traded in Other Exchanges
N/A
Address
132 Nathan Road, Suite 2310-18, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG
China Regenerative Medicine International Ltd is an investment holding company engaged in the provision of healthcare products and services. Its reportable segments are Aesthetic medical and beauty services and Medical services. The vast majority of the company's revenue is derived from its Aesthetic medical and beauty services segment. Geographically, the People's Republic of China accounts for the majority of the revenue. It also has a presence in Hong Kong.
Executives
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Wang Chuang 2101 Beneficial owner
Arab Osman Mohammed 2501 Other
Wong Kwok Keung 2501 Other
Lei Changjuan 2101 Beneficial owner
Chang Zhou Shi Zhong Min Xing Kong Qi Ye Guan Li Zi Xun Fu Wu He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Kong Yudong 2101 Beneficial owner
Chang Zhou Shi Yao Guang Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Li Ren 2201 Interest of corporation controlled by you
Nat-ace Wood Industry Ltd. (formerly Known As Forerunner Technology Limited) 2201 Interest of corporation controlled by you
All Favour Holdings Limited 2101 Beneficial owner
Deng Shufen 2202 Interest of your spouse
Dai Yumin 2201 Interest of corporation controlled by you
Wang Xiaogang 2101 Beneficial owner
China Orient Asset Management Co., Ltd. 2106 Person having a security interest in shares

China Regenerative Medicine International Headlines

No Headlines